Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction

Journal of Cardiovascular Medicine

Volumn 9, Issue 10, 2008, Pages 1023-1029

  De Luca, Giuseppe ^a   Savonitto, Stefano ^b   Greco, Cesare ^c   Parodi, Guido ^d   Dajelli Ermolli, Nevio C ^e   Silva, Caterina ^f   Lucci, Donata ^g   Gonzini, Lucio ^g   Maggioni, Aldo P ^g   Cuccia, Claudio ^h  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e OSPEDALE DI CIRCOLO   (Italy)

^f UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^g Italian Hospital Cardiology Association Research Center   (Italy)

^h Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

Author keywords

Cardiogenic shock; Mortality; Predictors; Reperfusion therapies

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY CARE UNIT; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; REPERFUSION; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; AGE; ANGIOCARDIOGRAPHY; EPIDEMIOLOGY; HEART MUSCLE REPERFUSION; HYPOTENSION; ITALY; MIDDLE AGED; RADIOGRAPHY; RISK FACTOR; TIME; TREATMENT FAILURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY CARE UNITS; DIABETES COMPLICATIONS; FEMALE; HEALTH CARE SURVEYS; HOSPITAL MORTALITY; HUMANS; HYPOTENSION; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; TIME FACTORS; TREATMENT FAILURE;

EID: 55249126888     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328304ae7f     Document Type: Article

References (21)

1. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341:1413-1419.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361:13-20.
3. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005; 293:1759-1765.
4. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Neumann FJ, Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J 2007; 153:343-353.
5. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110:588-636.
6. Hasdai D, Holmes DR, Topol EJ, Berger PB, Criger DA, Hochman JS, et al. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO III. Eur Heart J 1999; 20:128-133.
7. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, et al., The Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 2004; 25: 322- 328.
8. De Luca G, van't Hof AW, de Boer MJ, Hoorntje JC, Gosselink AT, Dambrink JH, et al. Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure. Circulation 2004; 109:958-961.
9. Berger PB, Tuttle RH, Holmes DR Jr, Topol EJ, Aylward PE, Horgan JH, et al. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. Circulation 1999; 99:873-878.
10. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al., SHOCK Investigators. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295:2511-2515.
11. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A, et al. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol 2008; 126:37-44.
12. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340:1162-1168.
13. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J, GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359:373-377.
14. Di Chiara A, Chiarella F, Savonitto S, Lucci D, Bolognese L, De Servi S, et al., on behalf of the BLITZ Investigators. Epidemiology of acute myocardial infarction in the Italian CCU network. The BLITZ study. Eur Heart J 2003; 24:1616-1629.
15. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979; 59:607-609.
16. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21:1502-1513.
17. Barbash IM, Hasdai D, Behar S, Boyko V, Gottlieb S, Ilia R, et al., Israeli Thrombolytic Survey Group. Usefulness of pre versus postadmission cardiogenic shock during acute myocardial infarction in predicting survival. Am J Cardiol 2001; 87:1200-1203; A7.
18. Lindholm MG, Kober L, Boesgaard S, Torp-Pedersen C, Aldershvile J, Trandolapril Cardiac Evaluation study group. Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development. Eur Heart J 2003; 24:258-265.
19. Federazione Italiana di Cardiologia-Societa Italiana di Cardiologia Invasiva. Consensus document: the interhospital network for coronary emergency. Ital Heart J 2005; 6 (Suppl 6):5S-26S.
20. Hasdai D, Califf RM, Thompson TD, Hochman JS, Ohman EM, Pfisterer M, et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 2000; 35: 136-143.
21. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.